Automation market to reach $3bn by 2012
Automation expenditures in pharma manufacturing are predicted to reach $3bn (€2.15bn) by 2012 because companies must invest in the current “adapt or die” environment, according to a report.
Automation expenditures in pharma manufacturing are predicted to reach $3bn (€2.15bn) by 2012 because companies must invest in the current “adapt or die” environment, according to a report.
German aseptic filling specialist Vetter has boosted packaging operations at its new facility in Ravensburg to meet growing demand for cost-effective secondary packaging services
Physicians say a lack of information about candidate drugs often prevents them referring patients for clinical trials, according to a new survey by sector analysts CenterWatch.
Excel Life Sciences (ELS) and PFC Pharma Focus have launched a joint venture in India in response to growing client demand for services in the country delivered by established and proven providers.
Seven of the top ten drugs will be biopharmaceuticals by 2014 according to sector analysts Evaluate Pharma.
Watson Pharmaceuticals is to acquire Arrow Group for $1.75bn (€1.26bn), adding to the company’s manufacturing network and providing it with the expertise needed to enter the biogenerics market.